Search results
Pfizer Inc. [PFE] Records 200-Day SMA of $30.85 – Knox Daily
Knox Daily· 22 hours agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Pfizer Inc. shares valued ...
Consolidated Portfolio Review Corp Has $316,000 Stock Holdings in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 4 days agoConsolidated Portfolio Review Corp decreased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 17.1% in the 4th quarter, according to its most recent ...
ProSource360 wins opportunity to partner with Pfizer through its Diverse OnDemand Marketplace
WTRF Wheeling· 9 hours agoFirm becomes one of only 11 selected to supply professional services through unique model! WASHINGTON, April 18, 2024 /PRNewswire/ -- ProSource360 announces it has been chosen to participate ...
Lee Howard: What's Going On: Pfizer putting $20 million-plus into local renovations
The Day· 4 days agoFILE- A Pfizer logo is shown at their global supply Kalamazoo manufacturing plant in Portage, Mich.,...
Pfizer-Connect Biopharma deal for inflammatory drug ends
Seeking Alpha· 1 day agoConnect Biopharma (CNTB) terminates licensing deal with Pfizer (PFE) for CBP-174, an oral...
Peninsula VC adds more than $100 million, brings on former Pfizer exec as partner - San Francisco...
The Business Journals· 1 day agoA leading biotech venture capital firm said it's added more than $100 million in capital and a seasoned industry voice in former Pfizer Inc. executive Uwe ...
Pfizer's 15-month fall: Will the stock ever recover? | Invezz
Invezz· 7 days agoPfizer Inc (NYSE:PFE) has been one of the worst-performing large-cap stocks over the last two years. The decline in the stock has been particularly painful ...
Pfizer wins pause on Moderna's COVID-19 patent lawsuit
Reuters· 6 days ago, opens new tab copied its COVID-19 vaccine technology will be put on hold while the U.S. Patent...
Biotechnology and Pharmaceuticals
The Wall Street Transcript· 22 hours ago:BMY ), Novartis AG ( NYSE:NVS ), Cabaletta Bio Inc. ( NASDAQ:CABA ), Kyverna Therapeutics Inc. ( NASDAQ:KYTX ), Pfizer, Inc ...
Big pharma: cautious optimism ahead of earnings season - analysts
Proactive Investors· 17 hours agoLooking ahead to the pharmaceutical earnings season, UBS expressed cautious optimism when looking at...
